Addex Therapeutics LtdADXNNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank29
3Y CAGR+4.0%
5Y CAGR-2.7%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+4.0%/yr
vs -32.7%/yr prior
5Y CAGR
-2.7%/yr
Recent acceleration
Acceleration
+36.7pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 13.69 | +545.8% |
| 2023 | 2.12 | -33.7% |
| 2022 | 3.20 | -73.7% |
| 2021 | 12.17 | -17.2% |
| 2020 | 14.70 | -6.2% |
| 2019 | 15.67 | +77.5% |
| 2018 | 8.83 | -85.1% |
| 2017 | 59.28 | -95.1% |
| 2016 | 1211.76 | +57.9% |
| 2015 | 767.43 | - |